Get started
Author

Mollie Lumpkin

Evaluation of Response to High-Dose Intravenous Vitamin K Administration
2023 · April R. Chapman, Jason R. Yerke, et al. · Annals of Pharmacotherapy · 7
Evaluation of a protocol for rifaximin discontinuation in critically ill patients with liver disease receiving broad-spectrum antibiotic therapy
2023 · Jessica A Ward, Jason Yerke, et al. · World Journal of Hepatology · 6
PDF
Impact of Duration of N-Acetylcysteine in Non-Acetaminophen–Induced Acute Liver Failure
2021 · Stephanie N. Bass, Mollie Lumpkin, et al. · Critical Care Explorations · 3
Impact of beta-lactam antibiotic renal dose adjustment on clinical outcomes in patients with septic shock and acute kidney injury from gram-negative bloodstream infections: a multicenter observational study
2025 · Melissa L. Thompson Bastin, Megan A Rech, et al. · CMI Communications · 2
PDF
Antipsychotic Use for ICU Delirium and Associated Inflammatory Markers
2023 · Heather Torbic, Alyssa Chen, et al. · Journal of Intensive Care Medicine · 2
PDF
Reply: Evaluation of Response to High-Dose Intravenous Vitamin K Administration
2023 · April R. Chapman, Jason R. Yerke, et al. · Annals of Pharmacotherapy
PDF
752: Evaluation of Response to High-dose Vitamin K Administration
2022 · Jason Yerke, Stephanie Bass, et al. · Critical Care Medicine
1206: Beta-lactam Dosing in Patients With Sepsis and Aki: a Multicenter Observational Study
2022 · Melissa Thompson Bastin, Megan Rech, et al. · Critical Care Medicine
895: Evaluation of Rifaximin Discontinuation in Critically Ill Liver Patients Receiving Antibiotics
2021 · Jessica Ward, Jason Yerke, et al. · Critical Care Medicine
478: Impact of the Duration of N-acetylcysteine for Non- Acetaminophen-induced Acute Liver Failure
2019 · Stephanie Bass, Mollie Lumpkin, et al. · Critical Care Medicine
Works count: 12
Citation count: 20
H-index: 3
I10-index:
Year
Topic
Type